Amalgamated Bank’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-21,745
Closed -$271K 1536
2016
Q4
$271K Buy
21,745
+2,989
+16% +$36K 0.01% 1194
2016
Q3
$257K Buy
18,756
+27
+0.1% +$271 0.01% 1116
2016
Q2
$190K Buy
18,729
+1,135
+6% +$8.52K 0.01% 1275
2016
Q1
$112K Buy
17,594
+1,514
+9% +$8.49K 0.01% 1214
2015
Q4
$101K Sell
16,080
-1,545
-9% -$10.1K 0.01% 1144
2015
Q3
$103K Buy
17,625
+303
+2% +$2.33K 0.01% 1236
2015
Q2
$143K Buy
17,322
+573
+3% +$5.07K 0.01% 1285
2015
Q1
$138K Buy
16,749
+649
+4% +$4.8K 0.02% 897
2014
Q4
$111K Buy
16,100
+24
+0.1% +$150 0.02% 829
2014
Q3
$87K Sell
16,076
-7
-0% -$41 0.01% 821
2014
Q2
$102K Sell
16,083
-4,752
-23% -$32.7K 0.02% 845
2014
Q1
$168K Sell
20,835
-155
-0.7% -$1.21K 0.03% 783
2013
Q4
$143K Buy
20,990
+4,811
+30% +$26K 0.02% 790
2013
Q3
$298K Buy
+16,179
New +$314K 0.1% 215

Other funds holding ARIA

Amalgamated Bank's ARIA Position: Q1 2017 in Review

Amalgamated Bank sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 21,745 shares — an estimated $271K sold.

Amalgamated Bank first reported a position in ARIA in Q3 2013 and held it in 14 quarters. The position peaked at $298K in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Amalgamated Bank reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Amalgamated Bank sold 21,745 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $271K.
  • Amalgamated Bank first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 14 quarters.
  • Amalgamated Bank's Ariad Pharmaceuticals Inc position peaked at $298K in Q3 2013.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Amalgamated Bank's 13F filing for Q1 2017, filed 12 May 2017.